These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26925846)

  • 1. New antidepressant use in older adults: a Canadian population-based study (1997-2013).
    Leong C; Enns MW; Sareen J; Alessi-Severini S; Bolton J; Prior HJ; Chateau D
    Aging Ment Health; 2017 Jul; 21(7):720-729. PubMed ID: 26925846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological justification for the use of new antidepressant drugs].
    Nowakowska E; Kus K; Bobkiewicz-Kozłowska T
    Pol Merkur Lekarski; 2002 Sep; 13(75):250-2. PubMed ID: 12474581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant switching among adherent patients treated for depression.
    Marcus SC; Hassan M; Olfson M
    Psychiatr Serv; 2009 May; 60(5):617-23. PubMed ID: 19411348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of antidepressants among elderly subjects: trends and contributing factors.
    Mamdani MM; Parikh SV; Austin PC; Upshur RE
    Am J Psychiatry; 2000 Mar; 157(3):360-7. PubMed ID: 10698810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
    Möller HJ; Kasper S; Müller H; Kissling W; Fuger J; Ruhrmann S
    Pharmacopsychiatry; 1995 Nov; 28(6):249-52. PubMed ID: 8773291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New formulations of existing antidepressants: advantages in the management of depression.
    Norman TR; Olver JS
    CNS Drugs; 2004; 18(8):505-20. PubMed ID: 15182220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A drug utilization review of prescribing patterns for trazodone versus amitriptyline.
    Bryant SG; Hokanson JA; Brown CS
    J Clin Psychiatry; 1990 Sep; 51 Suppl():27-9. PubMed ID: 2211562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer antidepressants in pregnancy: prospective outcome of a case series.
    Yaris F; Kadioglu M; Kesim M; Ulku C; Yaris E; Kalyoncu NI; Unsal M
    Reprod Toxicol; 2004 Dec; 19(2):235-8. PubMed ID: 15501389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
    Owen JR; Nemeroff CB
    Depress Anxiety; 1998; 7 Suppl 1():24-32. PubMed ID: 9597349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
    Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.
    Deuschle M; Angermeier T; Westphal S; Lederbogen F; Gilles M; Frankhauser P; Schilling C; Onken V; Weber-Hamann B; Kopf D
    Psychother Psychosom; 2010; 79(2):123-5. PubMed ID: 20090399
    [No Abstract]   [Full Text] [Related]  

  • 12. [The comparative studies of therapeutic results in patients with psychotic refractory depression treated with selected antidepressants and unilateral ECT].
    Hese RT; Gruszczyński W; Szwed A; Kielc M; Zalitacz M
    Psychiatr Pol; 2002; 36(6 Suppl):81-4. PubMed ID: 12647425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FPIN's clinical inquiries: Antidepressants for the treatment of insomnia in patients with depression.
    Clark MS; Smith PO; Jamieson B
    Am Fam Physician; 2011 Nov; 84(9):1-2. PubMed ID: 22164891
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK.
    Murray ML; Thompson M; Santosh PJ; Wong IC
    Drug Saf; 2005; 28(12):1151-7. PubMed ID: 16329717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
    Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
    J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant utilization in British Columbia from 1996 to 2004: increasing prevalence but not incidence.
    Raymond CB; Morgan SG; Caetano PA
    Psychiatr Serv; 2007 Jan; 58(1):79-84. PubMed ID: 17215416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
    Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
    CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A risk-benefit assessment of mirtazapine in the treatment of depression.
    Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
    Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.